FBT vs. LFSC
Compare and contrast key facts about First Trust Amex Biotechnology Index (FBT) and F/m Emerald Life Sciences Innovation ETF (LFSC).
FBT and LFSC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FBT is a passively managed fund by First Trust that tracks the performance of the NYSE Arca Biotechnology Index. It was launched on Jun 23, 2006. LFSC is an actively managed fund by F/m Investments. It was launched on Oct 30, 2024.
Performance
FBT vs. LFSC - Performance Comparison
Loading graphics...
FBT vs. LFSC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
FBT First Trust Amex Biotechnology Index | -2.76% | 24.25% | -1.66% |
LFSC F/m Emerald Life Sciences Innovation ETF | -4.45% | 56.54% | -6.02% |
Returns By Period
In the year-to-date period, FBT achieves a -2.76% return, which is significantly higher than LFSC's -4.45% return.
FBT
- 1D
- 4.05%
- 1M
- -3.77%
- YTD
- -2.76%
- 6M
- 12.01%
- 1Y
- 18.05%
- 3Y*
- 9.26%
- 5Y*
- 4.70%
- 10Y*
- 8.59%
LFSC
- 1D
- 6.16%
- 1M
- -3.82%
- YTD
- -4.45%
- 6M
- 17.66%
- 1Y
- 55.83%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FBT vs. LFSC - Expense Ratio Comparison
FBT has a 0.57% expense ratio, which is higher than LFSC's 0.54% expense ratio.
Return for Risk
FBT vs. LFSC — Risk / Return Rank
FBT
LFSC
FBT vs. LFSC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Amex Biotechnology Index (FBT) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT | LFSC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.73 | 1.93 | -1.19 |
Sortino ratioReturn per unit of downside risk | 1.17 | 2.65 | -1.47 |
Omega ratioGain probability vs. loss probability | 1.15 | 1.33 | -0.18 |
Calmar ratioReturn relative to maximum drawdown | 1.52 | 3.20 | -1.68 |
Martin ratioReturn relative to average drawdown | 4.09 | 8.96 | -4.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FBT | LFSC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.73 | 1.93 | -1.19 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.22 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.50 | 0.94 | -0.45 |
Correlation
The correlation between FBT and LFSC is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FBT vs. LFSC - Dividend Comparison
Neither FBT nor LFSC has paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FBT First Trust Amex Biotechnology Index | 0.00% | 0.00% | 0.71% | 0.00% | 0.00% | 1.37% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
FBT vs. LFSC - Drawdown Comparison
The maximum FBT drawdown since its inception was -40.51%, which is greater than LFSC's maximum drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for FBT and LFSC.
Loading graphics...
Drawdown Indicators
| FBT | LFSC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.51% | -29.74% | -10.77% |
Max Drawdown (1Y)Largest decline over 1 year | -14.26% | -16.25% | +1.99% |
Max Drawdown (5Y)Largest decline over 5 years | -29.05% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -32.37% | — | — |
Current DrawdownCurrent decline from peak | -9.48% | -11.08% | +1.60% |
Average DrawdownAverage peak-to-trough decline | -11.22% | -8.25% | -2.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.33% | 5.80% | -0.47% |
Volatility
FBT vs. LFSC - Volatility Comparison
The current volatility for First Trust Amex Biotechnology Index (FBT) is 8.93%, while F/m Emerald Life Sciences Innovation ETF (LFSC) has a volatility of 10.35%. This indicates that FBT experiences smaller price fluctuations and is considered to be less risky than LFSC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FBT | LFSC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.93% | 10.35% | -1.42% |
Volatility (6M)Calculated over the trailing 6-month period | 15.57% | 19.97% | -4.40% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.96% | 29.24% | -4.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.72% | 29.31% | -7.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.06% | 29.31% | -5.25% |